Lipocine Inc. (LPCN) › Operating Cash FlowLipocine Inc. (LPCN) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$7.3K2012: -$3.18M2013: -$8.59M2015: -$15.36M2016: -$18.28M2017: -$16.70M2018: -$12.08M2019: -$11.67M2020: -$15.30M2021: -$4.41M2022: -$11.97M2023: -$11.87M2024: -$1.22M2025: -$9.76M-$9.76M2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$9.76M-699.3%2024-$1.22M+89.7%2023-$11.87M+0.9%2022-$11.97M-171.3%2021-$4.41M+71.2%2020-$15.30M-31.2%2019-$11.67M+3.4%2018-$12.08M+27.7%2017-$16.70M+8.6%2016-$18.28M-19.1%2015-$15.36M—2013-$8.59M-170.2%2012-$3.18M-43469.5%2011-$7.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share